Skip to main content
TLX logo
TLX
(NASDAQ)
Telix Pharmaceuticals Limited
$11.94-- (--)
Loading... - Market loading

Telix Pharmaceuticals (TLX) Stock Price & Financial Analysis

Telix Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.84 - $11.95
52-Week High$12.48
52-Week Low$6.28
Open$11.84
Volume140.96K
Average Volume (3M)126.38K
Market Cap4.04B
Shares Outstanding338.78M
Price to Sales (P/S)5.03
Price to Book (P/B)9.74
EV/EBITDA84.17
Revenue (TTM)803.79M
Net Income (TTM)-7.13M
Free Cash Flow (TTM)-78.36M
EPS (TTM)$-0.02
Profit Margin-0.89%
Operating Margin3.70%
Return on Equity (ROE)-1.72%
Debt to Equity0.98
50-Day MA$11.19
200-Day MA$9.44
52-Week Change31.79%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateApr 18, 2006

Frequently Asked Questions About Telix Pharmaceuticals

What is the current stock price for TLX?

As of the latest trading session, TLX stock trades at $11.94. The 52-week range is $6.28–$12.48, with a day range of $11.84–$11.95.

What is the P/E ratio for TLX?

The P/E ratio (Price-to-Earnings) for TLX is shown in the Key Statistics section. This valuation metric helps compare Telix Pharmaceuticals Limited to industry peers.

Does TLX pay dividends?

Telix Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TLX?

Analyst ratings and recommendations for TLX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TLX?

Telix Pharmaceuticals's market capitalization is $4.04B, classifying it as a mid-cap company. Telix Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.